Speaker illustration

Miss Vian Kokabi

General Hospital Vienna, Vienna (Austria)

Safety of SGLT2-Inhibitors in cardio-oncology patients with heart failure undergoing cancer treatment

Event: ESC Cardio-Oncology 2025

Topic: Diagnosis and Management of Cardiovascular Disease in Patients with Cancer

Session: Poster session (2)

Thumbnail

ESC 365 is supported by